BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 11979558)

  • 1. Defective DNA-mismatch repair: a potential mediator of leukemogenic susceptibility in therapy-related myelodysplasia and leukemia.
    Olipitz W; Hopfinger G; Aguiar RC; Gunsilius E; Girschikofsky M; Bodner C; Hiden K; Linkesch W; Hoefler G; Sill H
    Genes Chromosomes Cancer; 2002 Jun; 34(2):243-8. PubMed ID: 11979558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microsatellite instability markers for identifying early-onset colorectal cancers caused by germ-line mutations in DNA mismatch repair genes.
    Mead LJ; Jenkins MA; Young J; Royce SG; Smith L; St John DJ; Macrae F; Giles GG; Hopper JL; Southey MC
    Clin Cancer Res; 2007 May; 13(10):2865-9. PubMed ID: 17504984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptotic and growth regulatory genes as mutational targets in mismatch repair deficient endometrioid adenocarcinomas of young patients.
    Vassileva V; Millar A; Briollais L; Chapman W; Bapat B
    Oncol Rep; 2004 Apr; 11(4):931-7. PubMed ID: 15010897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated sequences in CASPASE-5 and FANCD2 but not NF1 are targets for mutation in microsatellite-unstable acute leukemia/myelodysplastic syndrome.
    Offman J; Gascoigne K; Bristow F; Macpherson P; Bignami M; Casorelli I; Leone G; Pagano L; Sica S; Halil O; Cummins D; Banner NR; Karran P
    Mol Cancer Res; 2005 May; 3(5):251-60. PubMed ID: 15886296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defective DNA mismatch repair and XRCC2 mutation in uterine carcinosarcomas.
    Taylor NP; Gibb RK; Powell MA; Mutch DG; Huettner PC; Goodfellow PJ
    Gynecol Oncol; 2006 Jan; 100(1):107-10. PubMed ID: 16169065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific clinical and biological features characterize inflammatory bowel disease associated colorectal cancers showing microsatellite instability.
    Svrcek M; El-Bchiri J; Chalastanis A; Capel E; Dumont S; Buhard O; Oliveira C; Seruca R; Bossard C; Mosnier JF; Berger F; Leteurtre E; Lavergne-Slove A; Chenard MP; Hamelin R; Cosnes J; Beaugerie L; Tiret E; Duval A; Fléjou JF
    J Clin Oncol; 2007 Sep; 25(27):4231-8. PubMed ID: 17878476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microsatellite instability and DNA mismatch repair deficiency testing in hereditary and sporadic gastrointestinal cancers.
    Gologan A; Sepulveda AR
    Clin Lab Med; 2005 Mar; 25(1):179-96. PubMed ID: 15749237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced likelihood of metastases in patients with microsatellite-unstable colorectal cancer.
    Malesci A; Laghi L; Bianchi P; Delconte G; Randolph A; Torri V; Carnaghi C; Doci R; Rosati R; Montorsi M; Roncalli M; Gennari L; Santoro A
    Clin Cancer Res; 2007 Jul; 13(13):3831-9. PubMed ID: 17606714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of occult high graded microsatellite instabilities in MMR gene mutation negative HNPCC tumors by addition of complementary marker analysis.
    Schiemann U; Müller-Koch Y; Gross M; Glas J; Baretton G; Muders M; Mussack T; Holinski-Feder E
    Eur J Med Res; 2005 Jan; 10(1):23-8. PubMed ID: 15737950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genes involved in DNA repair are mutational targets in endometrial cancers with microsatellite instability.
    Vassileva V; Millar A; Briollais L; Chapman W; Bapat B
    Cancer Res; 2002 Jul; 62(14):4095-9. PubMed ID: 12124347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eight novel MSH6 germline mutations in patients with familial and nonfamilial colorectal cancer selected by loss of protein expression in tumor tissue.
    Plaschke J; Krüger S; Dietmaier W; Gebert J; Sutter C; Mangold E; Pagenstecher C; Holinski-Feder E; Schulmann K; Möslein G; Rüschoff J; Engel C; Evans G; Schackert HK;
    Hum Mutat; 2004 Mar; 23(3):285. PubMed ID: 14974087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy-related leukemia: clinical characteristics and analysis of new molecular risk factors in 96 adult patients.
    Rund D; Krichevsky S; Bar-Cohen S; Goldschmidt N; Kedmi M; Malik E; Gural A; Shafran-Tikva S; Ben-Neriah S; Ben-Yehuda D
    Leukemia; 2005 Nov; 19(11):1919-28. PubMed ID: 16167058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microsatellite instability and mismatch repair protein defects in ovarian epithelial neoplasms in patients 50 years of age and younger.
    Jensen KC; Mariappan MR; Putcha GV; Husain A; Chun N; Ford JM; Schrijver I; Longacre TA
    Am J Surg Pathol; 2008 Jul; 32(7):1029-37. PubMed ID: 18469706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microsatellite instability in multiple nonfamilial malignancies.
    Niv E; Bomstein Y; Bernheim J; Lishner M
    Mol Carcinog; 2006 Mar; 45(3):175-82. PubMed ID: 16385587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA mismatch repair, microsatellite instability and cancer.
    Vaish M; Mittal B
    Indian J Exp Biol; 2002 Sep; 40(9):989-94. PubMed ID: 12587725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular genetic alterations and clinical features in early-onset colorectal carcinomas and their role for the recognition of hereditary cancer syndromes.
    Losi L; Di Gregorio C; Pedroni M; Ponti G; Roncucci L; Scarselli A; Genuardi M; Baglioni S; Marino M; Rossi G; Benatti P; Maffei S; Menigatti M; Roncari B; Ponz de Leon M
    Am J Gastroenterol; 2005 Oct; 100(10):2280-7. PubMed ID: 16181381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of microsatellite instability in children treated for acute lymphocytic leukemia with elevated HPRT mutant frequencies.
    Kendall HE; Vacek PM; Finette BA
    Mutagenesis; 2004 Sep; 19(5):409-12. PubMed ID: 15388815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in two short noncoding mononucleotide repeats in most microsatellite-unstable colorectal cancers.
    Hienonen T; Sammalkorpi H; Enholm S; Alhopuro P; Barber TD; Lehtonen R; Nupponen NN; Lehtonen H; Salovaara R; Mecklin JP; Järvinen H; Koistinen R; Arango D; Launonen V; Vogelstein B; Karhu A; Aaltonen LA
    Cancer Res; 2005 Jun; 65(11):4607-13. PubMed ID: 15930278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Explaining the familial colorectal cancer risk associated with mismatch repair (MMR)-deficient and MMR-stable tumors.
    Aaltonen L; Johns L; Järvinen H; Mecklin JP; Houlston R
    Clin Cancer Res; 2007 Jan; 13(1):356-61. PubMed ID: 17200375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug treatment in the development of mismatch repair defective acute leukemia and myelodysplastic syndrome.
    Casorelli I; Offman J; Mele L; Pagano L; Sica S; D'Errico M; Giannini G; Leone G; Bignami M; Karran P
    DNA Repair (Amst); 2003 May; 2(5):547-59. PubMed ID: 12713812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.